Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 17, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-046471.pdf 0001193125-21-046471.rtf 0001193125-21-046471.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 12, 2021	SC 13G/A	An amendment to the SC 13G filing	0001104659-21-021132.pdf 0001104659-21-021132.rtf 0001104659-21-021132.xls View HTML
February 11, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000093751-21-000286.pdf 0000093751-21-000286.rtf View HTML
February 10, 2021	SC 13G/A	An amendment to the SC 13G filing	0000093751-21-000186.pdf 0000093751-21-000186.rtf View HTML
February 10, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-21-017368.pdf 0001104659-21-017368.rtf View HTML
February 3, 2021	SC 13G/A	An amendment to the SC 13G filing	0000902219-21-000057.pdf 0000902219-21-000057.rtf 0000902219-21-000057.xls View HTML
January 29, 2021	SC 13G/A	An amendment to the SC 13G filing	0000834237-21-002871.pdf 0000834237-21-002871.rtf View HTML
January 28, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-020824.pdf 0001193125-21-020824.rtf 0001193125-21-020824.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 28, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001562180-21-000573.pdf 0001562180-21-000573.rtf 0001562180-21-000573.xls View HTML
January 22, 2021	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-21-014727.pdf 0001193125-21-014727.rtf 0001193125-21-014727.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax